Diacerein-Loaded novel gastroretentive nanofiber system using PLLA: Development and in vitro characterization

Artificial Cells, Nanomedicine and Biotechnology

Volumn 44, Issue 3, 2016, Pages 928-936

  Malik, Raffi ^a   Garg, Tarun ^a   Goyal, Amit K ^a   Rath, Goutam ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

controlled release; floating behavior; gastroretention; nanofibers; solubility

Indexed keywords

CRYSTALLOGRAPHY; LACTIC ACID; NANOFIBERS; SOLUBILITY; TENSILE STRENGTH;

AMORPHOUS STATE; CONTROLLED RELEASE; DETACHMENT FORCES; ELECTROSPINNING TECHNIQUES; ELECTROSPUN NANOFIBERS; FLOATING BEHAVIOR; GASTRORETENTION; GASTRORETENTIVE DRUG DELIVERY SYSTEMS;

X RAY CRYSTALLOGRAPHY;

DIACEREIN; NANOFIBER; POLYLACTIC ACID; ANTHRAQUINONE DERIVATIVE; DRUG CARRIER; POLYESTER; POLYLACTIDE;

ARTICLE; BULK DENSITY; CHEMICAL STRUCTURE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; EVAPORATION; FLOATING LAG TIME; FLOATING TIME; IN VITRO STUDY; MUCOADHESION; PERMEABILITY; PHARMACOLOGICAL PARAMETERS; PHYSICAL APPEARANCE; POROSITY; SCANNING ELECTRON MICROSCOPY; SURFACE AREA; TENSILE STRENGTH; VISCOSITY; X RAY CRYSTALLOGRAPHY;

ANTHRAQUINONES; DRUG CARRIERS; NANOFIBERS; POLYESTERS;

EID: 84970024070     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2014.1000492     Document Type: Article

References (59)

1. A.Baji, Y.-W.Mai, S.-C.Wong, M.Abtahi, P.Chen. 2010. Electrospinning of polymer nanofibers: Effects on oriented morphology, structures and tensile properties. Compos Sci Technol. 70:703–718.
2. S.Chaudhary, T.Garg, R.S.Murthy, G.Rath, A.K.Goyal. 2014. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J Drug Target. 1–12.
3. S.Y.Chew, T.C.Hufnagel, C.T.Lim, K.W.Leong. 2006. Mechanical properties of single electrospun drug-encapsulated nanofibres. Nanotechnology. 17:3880.
4. T.Gagandeep, Garg, B.Malik, G.Rath, A.K.Goyal. 2014b. Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci. 53:10–16.
5. R.Garg, G.Gupta. 2008. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res. 7:1055–1066.
6. T.Garg. 2014. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. 1–8.
7. T.Garg, A.K.Goyal. 2012. Iontophoresis: drug delivery system by applying an electrical potential across the skin. Drug Deliv Lett. 2:270–280.
8. T.Garg, A.K.Goyal. 2014a. Biomaterial-based scaffolds–current status and future directions. Expert Opin Drug Deliv. 11:767–789.
9. T.Garg, A.K.Goyal. 2014b. Liposomes: targeted and controlled delivery system. Drug Deliv Lett. 4:62–71.
10. T.Garg, A.K.Goyal, S.Arora, R.Murthy. 2012a. Development, optimization & evaluation of porous chitosan scaffold formulation of gliclazide for the treatment of type-2 diabetes mellitus. Drug Deliv Lett. 2:251–261.
11. T.Garg, A.Kumar, G.Rath, A.K.Goyal. 2014a. Gastroretentive drug delivery systems for therapeutic management of peptic ulcer. Crit Rev Ther Drug Carrier Syst. 31:531–557.
12. T.Garg, G.Rath, A.K.Goyal. 2014b. Ancient and advanced approaches for the treatment of an inflammatory autoimmune disease-psoriasis. Crit Rev Ther Drug Carrier Syst. 31:331–364.
13. T.Garg, G.Rath, A.K.Goyal. 2014c. Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv.
14. T.Garg, O.Singh, S.Arora, R.Murthy. 2011a. Dendrimer—A novel scaffold for drug delivery. Int J Pharm Sci Rev Res. 7:211–220.
15. T.Garg, O.Singh, S.Arora, R.Murthy. 2011b. Patented microencapsulation techniques and its application. J Pharm Res. 4:2097–2102.
16. T.Garg, O.Singh, S.Arora, R.Murthy. 2012b. Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst. 29:1–63.
17. T.Garg, S.Singh, A.K.Goyal. 2013. Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst. 30:369–409.
18. A.K.Goyal, G.Rath, T.Garg. 2013a. Nanotechnological approaches for genetic immunization. DNA and RNA Nanobiotechnologies In Medicine: Diagnosis And Treatment Of Diseases. Erdmann, A.Volker, Barciszewski, hab. Jan (Eds.). Springer-Verlag Berlin Heidelberg, pp. 67–120.
19. G.Goyal, T.Garg, B.Malik, G.Chauhan, G.Rath, A.K.Goyal. 2013b. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv.
20. G.Goyal, T.Garg, G.Rath, A.K.Goyal. 2014a. Current nanotechnological strategies for an effective delivery of drugs in treatment of periodontal disease. Crit Rev Ther Drug Carrier Syst. 31:89–119.
21. G.Goyal, T.Garg, G.Rath, A.K.Goyal. 2014b. Current nanotechnological strategies for treating glaucoma. Crit Rev Ther Drug Carrier Syst. 31:365–405.
22. S.J.Grainger, M.E.H.El-Sayed. 2010. Stimuli-Sensitive particles for drug delivery. In: E.Jabbari, A.Khademhosseini, Eds. Biologically-Responsive Hybrid Biomaterials. Singapore: World Scientific, pp. 171–190.
23. T.Hussain, T.Garg, A.K.Goyal, G.Rath. 2014. Biomedical Applications of Nanofiber Scaffolds in Tissue Engineering. J Biomater Tiss Eng. 4:600–623.
24. M.Jaimini, A.Rana, Y.Tanwar. 2007. Formulation and evaluation of famotidine floating tablets. Curr Drug Deliv. 4:51–55.
25. H.S.Johal, T.Garg, G.Rath, A.K.Goyal. 2014. Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv. 1–14.
26. D.Joshi, T.Garg, A.K.Goyal, G.Rath. 2014. Advanced drug delivery approaches against periodontitis. Drug Deliv. 1–15.
27. V.Kalia, T.Garg, G.Rath, A.K.Goyal. 2014. Development and evaluation of a sublingual film of the antiemetic granisetron hydrochloride. Artif Cells Nanomed Biotechnol. 1–5.
28. K.Kataria, A.Sharma, T.Garg, A.K.Goyal, G.Rath. 2014. Novel technology to improve drug loading in polymeric nanofibers. Drug Deliv Lett. 4:79–86.
29. M.Kaur, T.Garg, R.K.Narang. 2014a. A review of emerging trends in the treatment of tuberculosis. Artif Cells Nanomed Biotechnol. 1–7.
30. M.Kaur, T.Garg, G.Rath, A.K.Goyal. 2014b. Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst. 31: 49–88.
31. M.Kaur, B.Malik, T.Garg, G.Rath, A.K.Goyal. 2014c. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv.
32. N.Kaur, T.Garg, A.K.Goyal, G.Rath. 2014d. Formulation, optimization and evaluation of curcumin-beta-cyclodextrin-loaded sponge for effective drug delivery in thermal burns chemotherapy. Drug Deliv. 1–10.
33. P.Kaur, T.Garg, G.Rath, R.S.Murthy, A.K.Goyal. 2014e. Surfactant-based drug delivery systems for treating drug-resistant lung cancer. Drug Deliv. 1–12.
34. R.Kaur, T.Garg, U.Das Gupta, P.Gupta, G.Rath, A.K.Goyal. 2014f. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Artif Cells Nanomed Biotechnol. 1–6.
35. R.Kaur, T.Garg, G.Rath, A.K.Goyal. 2014g. Advanced aerosol delivery devices for potential cure of acute and chronic diseases. Crit Rev Ther Drug Carrier Syst. 31:495–530.
36. V.Kaur, T.Garg, G.Rath, A.K.Goyal. 2014h. Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. J Drug Target. 22:859–870.
37. R.Malik, T.Garg, A.K.Goyal, G.Rath. 2014. Polymeric nanofibers: targeted gastro-retentive drug delivery systems. J Drug Target. 23:109–124.
38. H.Marwah, T.Garg, A.K.Goyal, G.Rath. 2014. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 1–15.
39. Z.Meng, X.Xu, W.Zheng, H.Zhou, L.Li, Y.Zheng, X.Lou. 2011. Preparation and characterization of electrospun PLGA/gelatin nanofibers as a potential drug delivery system. Colloids Surf B Biointerfaces. 84:97–102.
40. V.Modgill, T.Garg, A.K.Goyal, G.Rath. 2014. Permeability study of ciprofloxacin from ultra-thin nanofibrous film through various mucosal membranes. Artif Cells Nanomed Biotechnol. 1–6.
41. A.Morie, T.Garg, A.K.Goyal, G.Rath. 2014. Nanofibers as novel drug carrier – an overview. Artif Cells Nanomed Biotechnol. 1–9.
42. S.Pabreja, T.Garg, G.Rath, A.K.Goyal. 2014. Mucosal vaccination against tuberculosis using Ag85A-loaded immunostimulating complexes. Artif Cells Nanomed Biotechnol. 1–8.
43. V.Pillay, C.Dott, Y.E.Choonara, C.Tyagi, L.Tomar, P.Kumar,. 2013. A review of the effect of processing variables on the fabrication of electrospun nanofibers for drug delivery applications. J Nanomater.
44. R.Rohilla, T.Garg, J.Bariwal, A.K.Goyal, G.Rath. 2014a. Development, optimization and characterization of glycyrrhetinic acid-chitosan nanoparticles of atorvastatin for liver targeting. Drug Deliv. 1–8.
45. R.Rohilla, T.Garg, A.K.Goyal, G.Rath. 2014b. Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Deliv. 1–17.
46. M.Semalty, A.Semalty, G.Kumar. 2008. Formulation and characterization of mucoadhesive buccal films of glipizide. Indian J Pharm Sci. 70:43–48.
47. A.Sharma, T.Garg, A.Aman, K.Panchal, R.Sharma, S.Kumar, T.Markandeywar. 2014a. Nanogel-an advanced drug delivery tool: current and future. Artif Cells Nanomed Biotechnol. 1–13.
48. R.Sharma, T.Garg, A.K.Goyal, G.Rath. 2014b. Development, optimization and evaluation of polymeric electrospun nanofiber: a tool for local delivery of fluconazole for management of vaginal candidiasis. Artif Cells Nanomed Biotechnol. 1–8.
49. R.Sharma, H.Singh, M.Joshi, A.Sharma, T.Garg, A.K.Goyal, G.Rath. 2014c. Recent advances in polymeric electrospun nanofibers for drug delivery. Crit Rev Ther Drug Carrier Syst. 31:187–217.
50. B.Singh, T.Garg, A.K.Goyal, G.Rath. 2014a. Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol. 1–10.
51. H.Singh, R.Sharma, M.Joshi, T.Garg, A.K.Goyal, G.Rath. 2014b. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artificial Cells Nanomed Biotechnol. 1–7.
52. K.Singh, N.Arora, T.Garg. 2012a. RFID: a trustable security tool in pharmaceutical industry. Am J Pharm Tech Res. 2:113–127.
53. K.Singh, N.Arora, T.Garg. 2012b. Superbug: Antimicrobial resistance due to NDM-1. IJIPLS. 2:58–66.
54. O.Singh, T.Garg, G.Rath, A.K.Goyal. 2014c. Microbicides for the treatment of sexually transmitted HIV infections. J Pharmaceutics. 1–18.
55. P.Taepaiboon, U.Rungsardthong, P.Supaphol. 2007. Vitamin-loaded electrospun cellulose acetate nanofiber mats as transdermal and dermal therapeutic agents of vitamin A acid and vitamin E. Eur J Pharm Biopharm. 67:387–397.
56. A.Wade, P.J.Weller. 1994. Handbook of pharmaceutical excipients, Washington: American Pharmaceutical association, London: pharmaceutical press.
57. X.Xu, Q.Yang, Y.Wang, H.Yu, X.Chen, X.Jing. 2006. Biodegradable electrospun poly (L-lactide) fibers containing antibacterial silver nanoparticles. Euro Polym J. 42:2081–2087.
58. D.-G.Yu, L.-M.Zhu, K.White, C.Branford-White. 2009a. Electrospun nanofiber-based drug delivery systems. Health. 1:67.
59. D.Yu, X.Zhang, X.Shen, C.Branford-White, L.M.Zhu. 2009b. [The improvement of poorly water-soluble drug solubility through electrospun drug-loaded nanofibers]. Yao Xue Xue Bao = Acta pharmaceutica Sinica. 44:1179–1182.